Clinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreUncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read MoreAntibiotic Resistance: A Threat to All Of Us
When germs no longer respond to antibiotics, the cost to our health and budgets is enormous
Read MoreWhy is prenatal care vital to a happy and healthy pregnancy?
Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.
Read MoreHow to improve specialty drug adherence for patients with inflammatory conditions
To mitigate nonadherence for inflammatory condition treatments, plan sponsors should adopt a multifaceted approach that combines clinical protocols and value-based solutions.
Read MoreUnderstanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreThe Need for Comprehensive Fertility Benefits: A Patient Perspective
More and more individuals are turning to fertility treatment as a way to start a family. Employers who offer comprehensive fertility benefits provide peace of mind in helping employees reach their per...
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read More